Track your FDA device registration before December 31

1. What are FDA device registration and listing?

The requirements sit at 21 CFR Part 807. An owner or operator of an establishment engaged in the manufacture, preparation, propagation, compounding, assembly or processing of a device intended for human use has to register that establishment with FDA and submit listing information for the devices it has in commercial distribution. Registration answers who and where: the establishment's name and address, the owner or operator, an official correspondent, and every trade name the establishment uses. Listing answers what: the devices, their product codes or premarket submission numbers, and each activity performed on them at each site — manufacturing, repacking, relabeling, developing specifications, remanufacturing, contract sterilizing, single-use device reprocessing, or manufacturing for export only.

Both are submitted electronically through FDA's device registration and listing system, and both are reviewed on the same annual clock. Remindax helps you hold that clock — the annual window, the fee step inside it, and the change deadlines that run outside it — and reminds the people who have to act. It doesn't register establishments, list devices, file in FURLS, pay user fees, act as a U.S. Agent, or provide regulatory, quality-system or legal consulting.

Because a device establishment rarely carries this obligation alone — there are quality-system records, supplier certificates, calibration intervals, sterilization validations and facility permits around it — the registration and listing dates belong in the same register as everything else the site owes, which is what compliance tracking software is for: tracking and reminders, not a GRC suite or a QMS.

1.1 Who must register, by role

This is the part that decides how many renewals a company actually owes, and it is organised around activities rather than around who owns the product. The rule names the parties directly:

• →Manufacturers of finished devices. The establishment where the device is made, including contract manufacturers making it for somebody else. The obligation attaches to the establishment performing the work, not to whoever's name is on the label.
• →Specification developers. Anyone who initiates or develops specifications for a device that a second party will manufacture. A company with no factory at all can be a registering establishment on this basis alone — which surprises firms that outsourced production precisely to avoid running a plant.
• →Contract sterilizers. Anyone who sterilizes or otherwise makes a device for or on behalf of a specification developer or any other person. The sterilizer registers for the sterilizing, and its customer registers for whatever its customer does.
• →Repackagers and relabelers. Changing the package or the label is itself a listed activity, and it brings its own registration with it.
• →Reprocessors of single-use devices that have previously been used on a patient.
• →Initial importers. The party that first receives the device in the United States. Initial importers who did not develop the specifications, repackage or relabel may meet their listing obligation by submitting the manufacturer's name and address — but they must still be prepared to give FDA the proprietary and common names of each device on request.
• →Makers of components and accessories that are ready to be used for a health-related purpose and are packaged or labeled for commercial distribution for it — the rule's own examples include blood filters and hemodialysis tubing.
• →Foreign establishments that manufacture, prepare, propagate, compound or process a device imported or offered for import into the U.S. — each of which must also designate a U.S. Agent, covered in section 2.

One sequencing point matters more than its length suggests. If a device requires premarket clearance or approval, the establishment cannot register and list it until that submission has been cleared or approved. Registration is therefore downstream of a process whose timing is not entirely in your hands, and a firm waiting on a decision in November is waiting on two clocks at once — one it can plan and one it cannot.

2. When must FDA device registration be renewed?

The first two rows are the ones to fix in a calendar, and it is worth being clear that they are two rows rather than one. Registration and listing are reviewed together, in the same 92 days, through the same account — which makes it very easy to think of them as a single act. The rule does not. It states the annual registration requirement in one paragraph and the annual listing review in another, and the misbranding provision that gives them teeth reaches them separately too: a device is misbranded if it was made in an establishment not duly registered, or if it was not included in a required list. A company can be perfectly registered and still have a product that is misbranded because a listing was never confirmed.

The third row is where most of the December failures actually live, and it deserves more attention than it usually gets. Almost every other renewal on this site is a single act performed before a date. This one is a chain: pay, wait for the payment to process, receive the PIN and PCN, then use them to complete a registration in FURLS. FDA's own instruction is to plan to submit payment in advance of when you need to complete registration, precisely because the confirmation numbers take several days to arrive. That converts a hard December 31 deadline into a soft internal deadline some days earlier — and unlike the December 31 date, the internal one is not published anywhere. Every company has to set it for itself, and a company that sets it in the last week of December has effectively set it after the real one.

The fourth row is the part that keeps this from being a once-a-year item. Registration information — the establishment's address, the owner or operator, the official correspondent, trade names — has to be updated within 30 days of a change, not held over until the autumn. A new establishment beginning a covered activity registers within 30 days of starting it. And foreign establishments carry a tighter one that is easy to miss entirely: a change to the U.S. Agent's name, address or phone number must be reported within 10 business days. That is a shorter fuse than anything else in the part, attached to a detail — a contact's phone number — that changes for reasons that have nothing to do with regulatory affairs and are rarely routed to them.

Foreign establishments have two further recurring items worth putting on the same calendar. Each must designate exactly one U.S. Agent, who has to reside or maintain a place of business in the United States and who may also serve as the official correspondent; FDA can treat information given to that agent as having been given to the establishment. And upon initial registration, annually, and at the time of any changes, a foreign establishment must submit the identity of each importer of its devices that it knows of, and of each person who imports or offers them for import — including agents and brokers used to facilitate the import. That is a second annual obligation that depends on information held by the commercial side of the business rather than by regulatory, and it moves whenever a distributor relationship does.

3. Why tracking device registration dates matters

An annual deadline on a published date sounds like the easiest thing on a compliance calendar to hold. Four properties of this one explain why it is not:

There is a fifth property that is harder to put in a box, and it is about who notices. The window closes on December 31, but nothing happens on January 1 that a company can see from the inside. Production continues. Orders ship. The consequence surfaces later and elsewhere — when a customer's supplier-qualification team runs a check against FDA's public registration database and finds the establishment is not listed as active, or when a shipment is stopped at the border and someone has to explain why. The gap between the failure and the discovery of the failure is measured in weeks or months, and in that gap product keeps moving under a status nobody has looked at.

That delay is also what makes the fee worth tracking as its own line rather than as an assumed part of the renewal. The establishment registration fee is substantial, it is re-set by FDA for every fiscal year, and it is not reduced the way premarket submission fees are for small businesses — there is no published small-business rate for it. What does exist is narrower and has to be applied for: FDA may grant a waiver of the annual establishment registration fee, excluding the initial registration, to certain small businesses qualified through its Small Business Determination program who demonstrate that paying the fee represents a financial hardship. That is a determination to pursue in advance, on its own timetable, not a discount that appears at checkout in December.

4. Who needs to track device registration and listing

Firms whose whole business is devices generally know the obligation exists. The interesting list is the establishments that acquired it sideways — by outsourcing, by importing, by performing one step of somebody else's process — and the people whose job it quietly became:

Device manufacturers

The registration, the listing review and the user fee, every fiscal year, per site — alongside the quality and facility dates the same team already carries. The registration is the one with no internal process generating it.

Learn More

Specification developers

A design and commercial team with no production of its own is still a registering establishment, because initiating or developing specifications is itself a covered activity. Firms that outsourced manufacturing to shed facility obligations kept this one.

Contract manufacturers & sterilizers

Sterilizing, repacking, relabeling or reprocessing on somebody else's product each carries its own registration and its own listed activity. The customer's compliance does not cover the contractor's, and the contractor's does not cover the customer's.

Initial importers

The first U.S. recipient registers in its own right, and sits beside the import paperwork that already has dates on it. A lapse here is felt fastest, because the consequence lands where the goods cross.

Learn More

Foreign manufacturers & U.S. Agents

The registration, the single U.S. Agent designation with its 10-business-day change rule, and the annual identification of importers and of anyone who offers the devices for import — three obligations on three different rhythms.

Learn More

Regulatory affairs & quality teams

The people who own the window in practice, and who need the fee raised with finance early enough for the confirmation numbers to clear. Usually the same small group carrying every other date the site owes.

Learn More

Two of those groups are worth pairing, because the failure mode between them is the one that catches companies who thought they had this covered. A specification developer and its contract manufacturer each register, and each does so for what it does. Neither registration substitutes for the other, and neither party receives any notice when the other's lapses. A firm that has outsourced production has therefore outsourced neither the obligation nor the risk: its own registration is its own to renew, and its manufacturer's status is something it has to ask about rather than assume. The same is true in reverse for a contract manufacturer whose customer quietly fell out of registration — and it is why supplier-side registration status belongs in the same file as supplier certificates and insurance.

5. What happens when FDA device registration lapses

The device-registration failure is deceptively small in effort and large in consequence. Because the obligation is annual rather than one-time, a company that registered correctly at launch can lapse the very next year simply by not returning to FDA's system during October to December to renew its registration and confirm its listing — a step required even when nothing has changed. Nothing about the lapse is loud. No inspector arrives, no letter is issued on January 1, and no internal system flags it, because the act that was missed produced no artifact whose absence anyone would notice.

What changes first is status. The rule is direct about it: failing to submit the required information on time puts the establishment into a “failed to register” or “failed to list” status, the establishment is not considered active, and its registration and listing information may not appear on FDA's public website until the submission is made and processed. That last clause is the one with commercial teeth, because that website is where other people check. Hospital supply chains, group purchasing organizations, distributors and importers routinely verify that a supplier's establishment is registered and its devices listed. A company can discover its own lapse by being asked about it by a customer — which is a worse way to find out than almost any alternative.

Underneath the status sits the legal consequence, and it is sharper than the administrative one. Under the Federal Food, Drug, and Cosmetic Act a device is misbranded if it was manufactured, prepared, propagated, compounded or processed in an establishment not duly registered, or if it was not included in a required list. Misbranding is not a warning or a step in a process. It is a characteristic of the product, it attaches while the lapse persists, and it is the basis on which enforcement action and, for imported goods, detention at the point of entry proceed. The company that misses the window is not merely late with a form; every unit it ships in the meantime carries a defect that has nothing to do with how it was made.

The disruption spreads outward from there in a way that is disproportionate to the original omission. Devices held at the border do not reach the distributor who ordered them, who does not supply the hospital that scheduled around them — none of whom did anything wrong, and all of whom now have a supplier problem to document. Remediation is not instant either: the fee has to be paid, the payment has to process, the confirmation numbers have to be applied, and the corrected information has to be processed by FDA before it appears publicly again. A lapse discovered in February is not closed in February.

And because registration follows activities and establishments rather than corporate boundaries, a group can be in two states at once. The manufacturing entity can be current while the specification developer is lapsed, or the U.S. importing arm current while the foreign plant that supplies it is not — and under the import rule, no device may be imported or offered for import unless it is the subject of a required listing and was made at a registered foreign establishment. One entity's good standing offers the others nothing. Tracking the annual window, the fee step inside it, the listing confirmation and the change deadlines — for every registered establishment, not for the company as a whole — is what keeps the devices in lawful commercial distribution.

6. How Remindax keeps every registration current

Remindax holds the dates and reminds the people who have to act on them. It does not register establishments, list devices, file anything in FURLS, pay user fees, or act as a U.S. Agent, and it is not a regulatory, quality-system or legal consulting service.

One thing about how a reminder should be aimed here, because it differs from most obligations on this site. On a typical renewal it is enough that the alert reaches whoever owns the task. This one has two owners on the same deadline: regulatory affairs completes the submission, but finance has to release the establishment fee first, and the submission cannot be completed until that payment has processed. A reminder that reaches only regulatory in mid-December has surfaced the deadline to the person who cannot act alone on it. Setting the earlier alert to reach finance, and the later one to reach the person who will apply the confirmation numbers, is most of the value — and it is the whole reason to hold the fee step as a date rather than as an assumed part of the renewal.

7. Why spreadsheets fail for device registration tracking

A spreadsheet is a reasonable tool for dates that are known in advance, arrive on schedule, and are satisfied by a single act. Device registration fails all three tests, and it fails them in ways a cell cannot express.

The first problem is the word most of these spreadsheets actually contain. A row that says Registered, with a date in it, is a true statement about the past and a misleading one about the present, because it does not carry the fact that the status expires at the end of the calendar year and has to be re-earned in the fourth quarter of every one that follows. The cell looks the same in a year the renewal was done and a year it was not. Nothing in the sheet distinguishes an establishment that is registered from one that was registered.

The second is that the sheet holds one date where the obligation has three. Registration, listing confirmation and the fee are separate steps that can each be complete or not, in any combination — and the fee has to be finished first for the other two to be possible at all. A single December 31 entry cannot tell you that the fee was paid on the 29th and is still processing, which is precisely the state a company most needs to see and the one it is least likely to record.

The third is that the deadlines that hurt most are the ones that are not in the sheet at the time it is written. A registration change starts a 30-day clock on the day the change happens. A U.S. Agent's phone number changing starts a 10-business-day clock on a day nobody scheduled. Those dates cannot be entered in advance because they do not exist in advance, and a spreadsheet only ever contains the deadlines somebody thought of on the day they built it.

And the fourth is the one that scales badly. A group with several registered establishments has several independent renewals, and a spreadsheet flattens them into a single tab that reads as a single status. One entity current and another lapsed looks, at a glance, like a company that is on top of this — right up to the point where a customer checks the public database and finds otherwise. An automated system holds each establishment's window, its fee step, its listing confirmation and whatever change clocks are currently running, and reminds the right person before each — so every registration stays active, and every device stays in lawful distribution.

8. Key takeaways

• ✓FDA device establishment registration is annual, not one-time, and must take place between October 1 and December 31 of each fiscal year — for every establishment, every year.
• ✓Device listing is reviewed in the same window and is a separate obligation: the accuracy of all information on file must be confirmed each year regardless of whether anything changed.
• ✓The establishment registration user fee must be paid before registration can be completed, and FDA notes that receiving the PIN and PCN typically takes several days — so the practical deadline sits earlier than December 31.
• ✓Registration follows activities: manufacturers, specification developers, contract sterilizers, repackagers and relabelers, reprocessors, initial importers and foreign establishments each register for what they do.
• ✓A wholesale distributor that does not manufacture, repackage, process or relabel is not caught by these requirements — while a company with no factory at all can be, if it develops specifications.
• ✓Not everything waits for the window: registration changes carry a 30-day deadline, a new covered activity carries 30 days to register, and a foreign establishment's U.S. Agent details carry 10 business days.
• ✓Missing the window puts the establishment in a “failed to register” or “failed to list” status, removes it from FDA's public listing, and misbrands the devices — a status that attaches to the product and drives enforcement and import detention.
• ✓Tracking the window, the fee step, the listing confirmation and the change clocks — per establishment rather than per company — is what keeps devices in lawful commercial distribution.